Featured
Last news

Search for doomed MH370 resumes 11 years after disappearance
A fresh search for Malaysia Airlines flight MH370 has been launched more than a decade after the plane went missing in one of aviation's greatest enduring mysteries.

New Syria leader vows state 'monopoly' on weapons
Syria's new interim president pledged on Tuesday to ensure the state has a monopoly on weapons at a national dialogue conference on the country's future after Bashar al-Assad's overthrow.
Ailing pope resting amid slight improvement: Vatican
A critically ill Pope Francis, battling pneumonia in both lungs, slept well, the Vatican said Tuesday after earlier reporting a "slight improvement" in the health of the 88-year-old.

Ailing pope 'rested well' amid improvement: Vatican
A critically ill Pope Francis, who is battling pneumonia in both lungs, "rested well", the Vatican said Tuesday after earlier reporting a "slight improvement" in the condition of the 88-year-old.

Milan Fashion week opens as luxury sector struggles
Flair and fanfare promise to light up the Milan Fashion Week catwalks starting Tuesday, but upcoming shows will struggle to distract from a worrying slump in the luxury sector.

What happens next in S. Korea as Yoon's impeachment trial wraps up
South Korea's ousted President Yoon Suk Yeol's impeachment trial wraps up on Tuesday, capping weeks of high political drama following his shock decision to declare martial law.

Judge declines to immediately grant AP access to White House events
A US judge on Monday declined to immediately order the White House to restore full access to President Donald Trump's events to the Associated Press news agency.

Leafbuyer Technologies, Inc. Announces Record Results: 20% Increase in Quarterly Revenue, 68% Increase in Gross Margins and 134% Increase in Net Income
Financial Highlights:Revenue rose 20% from $1,434,132 to $1,717,127 in the third quarter of fiscal year 2024Expanding Profit Margins: Gross Margins increased 68% Year to YearNet Income increased 134% from ($220,010) loss to $78,815 in the same period

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
HALIFAX, NS / ACCESS Newswire / February 25, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows MedMira to expedite its growth in the Canadian market with the recently Health Canada approved Multiplo® TP/HIV rapid antibody test and its Reveal® G4 HIV-1/2 rapid antibody test. Both products have been granted Class 4 Medical Device Licenses, the highest regulatory classification for medical diagnostics in Canada.

1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million
VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its fourth quarter ("Q4 2024") and audited annual financial results for the years ended July 31, 2024 and 2023 ("Fiscal 2024"). All amounts expressed are in Canadian dollars.

NHI Announces First Quarter 2025 Dividend
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to stockholders of record as of March 31, 2025.

NHI Issues Investor Update
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:

NHI Announces Fourth Quarter 2024 Results
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2024.

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, March 7-11, 2025.

CGFNS International to Change Its Name to TruMerit
Rebranding heralds greater focus on building a future-ready global healthcare workforce

TPT Global Tech Launches First Super App in the United States With VuMe Live
TPT Global Tech Launches First Super App in the United States with VüMe Live

Specialty Coffee Expo to Feature the World Coffee Roasting Championship During Flagship Event April 25-27 In Houston, TX
Other Competitions Include Coffee Design Awards and Best New Product Awards

Revolutionizing Mental Health: AI-Powered Facial Screening Technology Set for Clinical Trials
Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effective method for detecting depressive symptoms through facial analysis.NIMS software is integrated into an app, that analyzes facial features from high-definition images captured by a mobile phone or desktop device.The clinical trials will assess NIMS's accuracy, reliability, and scalability for widespread use.Successful trial results will support regulatory approval, paving the way for Synbio to integrate NIMS into clinical and corporate settings.

viemaa Revolutionizes Hair Care with a Patented Biomimetic Cuticle Technology
Innovative hair care brand merges science with style to formulate products that repair and strengthen all hair types, and empower women with confidence, self-expression, and noticeably healthy hair.

StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use
Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers

Xebra Brands Unveils Strategic 2025 Roadmap to Accelerate Growth in North American CBD Market
VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) is pleased to announce the development of the Strategic 2025 Roadmap, a comprehensive commercial growth plan designated to expand its footprint in the North American CBD market. Developed in collaboration with a consulting firm specializing in Cannabis and CBD, the Strategic 2025 Roadmap outlines a clear roadmap to drive accelerated growth and market penetration. This strategic initiative positions Xebra to capitalize on emerging opportunities and strengthen its competitive presence in the rapidly evolving CBD industry.

Dolphin Subsidiary the Door Announces Major Roster of Chef and Lifestyle Talent for 2025 Showcasing Its Prowess for Culinary Launches and Brand Expansion
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / The Door, a subsidiary of Observer's 2025 Agency of The Year Dolphin (NASDAQ:DLPN) and a leader in culinary and lifestyle PR and integrated marketing, is expanding its line up of chef and lifestyle talent for 2025. Known for representing and marketing some of the most prominent hospitality entities, culinary icons, and food and beverage consumer brands-this latest group of clients further solidifies The Door's expertise in guiding chefs and lifestyle figures through successful brand expansions such as cookbooks, restaurants and strategic partnerships.

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
- This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Collaboration Agreement with Revance to study DMT410 for the treatment of axillary hyperhidrosis -- The Company also has an issued patent in Japan covering their DMT410 program for the treatment of hyperhidrosis -

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is completeTest results support the next development step with Phase 1clinical trial expected to commence in AprilProvides Summary of Expected 2025 Milestones

CTT Pharma Gives Update On U.S. and European Patents
TAMPA, FL / ACCESS Newswire / February 25, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) has received notification of an intention to grant from the European Patent Office(EPO) for additional claims to our original European Patent. CTT Pharma already received an intention to grant from the EPO for our micelle delivery but opted to further define and strengthen our patent for diabetes related drugs. Since, the patent for the diabetes drug Liraglutide has expired CTT will seek to find opportunities to utilize our micelle technology for Liraglutide. CTT also believes our technology could offer an enhanced drug delivery system for pharmaceutical companies with current diabetes drugs that are patented and for drugs in development. Furthermore, CTT is actively working on strengthening our patents in the United States and Europe and will look to file provisional patents in 2025 to continue to protect and strengthen our technology. CTT will update shareholders on additional provisional patents once they are filed and how they will be used to help with future development.

Forte Group Closes Strategic Initiatives to Strengthen Financial Position
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Moderna to Present at Upcoming Conferences in March 2025
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences:

LFTD Partners Entering Marijuana Industry in Illinois
Plans to acquire multiple Illinois Cannabis Licenses, a lease for marijuana product manufacturing in Skokie, IL, and industrial buildings and retail businesses in Rockford, IL

DR Congo PM says 'more than 7,000 dead' in war-torn east
DR Congo's prime minister said Monday that "more than 7,000" people have been killed in the east of the country since January, when the Rwanda-backed M23 group seized two major cities.

South Carolina to carry out first US firing squad execution since 2010
A South Carolina man convicted of murdering his ex-girlfriend's parents has chosen to be put to death by firing squad next month in what would be the first such execution in the United States since 2010.

EU vows to enforce digital rules despite Trump tariff warning
The EU promised on Monday to enforce its digital rules and to defend its laws "decisively" if necessary, after US President Donald Trump threatened to slap tariffs on countries that levy digital taxes on US tech firms.
Paedophile French surgeon in sex abuse trial admits to 'hideous' acts
A former French surgeon went on trial Monday charged with raping or sexually assaulting almost 300 patients, most of them children at the time, in one of the country's largest child sex abuse cases.